| Stereochemistry | EPIMERIC |
| Molecular Formula | C14H13N5O5S2 |
| Molecular Weight | 395.414 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12SCC3=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C4=CSC(N)=N4)C(=O)OC3C
InChI
InChIKey=UEHIFMGCXPDQOP-CXMNRGBSSA-N
InChI=1S/C14H13N5O5S2/c1-4-5-2-25-12-8(11(21)19(12)9(5)13(22)24-4)17-10(20)7(18-23)6-3-26-14(15)16-6/h3-4,8,12,23H,2H2,1H3,(H2,15,16)(H,17,20)/b18-7-/t4?,8-,12-/m1/s1
| Molecular Formula | C14H13N5O5S2 |
| Molecular Weight | 395.414 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
